We split the candidate features into four groups: (i) clinical variables (i.e., gender, age, pretreatment, and pathologic stage); (ii) mutation status of three well-known melanoma driver genes (BRAF, NRAS, and NF1); (iii) mutation load; and (iv) ECPAcell. The gene discussed is NRAS; the disease is melanoma.